These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 22824766

  • 1. Bone density and bone metabolism in patients with inflammatory bowel disease.
    Shirazi KM, Somi MH, Rezaeifar P, Fattahi I, Khoshbaten M, Ahmadzadeh M.
    Saudi J Gastroenterol; 2012; 18(4):241-7. PubMed ID: 22824766
    [Abstract] [Full Text] [Related]

  • 2. Bone mineral density in Iranian patients with inflammatory bowel disease.
    Zali M, Bahari A, Firouzi F, Daryani NE, Aghazadeh R, Emam MM, Rezaie A, Shalmani HM, Naderi N, Maleki B, Sayyah A, Bashashati M, Jazayeri H, Zand S.
    Int J Colorectal Dis; 2006 Dec; 21(8):758-66. PubMed ID: 16463035
    [Abstract] [Full Text] [Related]

  • 3. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.
    Ardizzone S, Bollani S, Bettica P, Bevilacqua M, Molteni P, Bianchi Porro G.
    J Intern Med; 2000 Jan; 247(1):63-70. PubMed ID: 10672132
    [Abstract] [Full Text] [Related]

  • 4. The frequency of low bone mineral density and its associated risk factors in patients with inflammatory bowel diseases.
    Ezzat Y, Hamdy K.
    Int J Rheum Dis; 2010 Aug; 13(3):259-65. PubMed ID: 20704624
    [Abstract] [Full Text] [Related]

  • 5. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease.
    Jahnsen J, Falch JA, Mowinckel P, Aadland E.
    Scand J Gastroenterol; 2002 Feb; 37(2):192-9. PubMed ID: 11843057
    [Abstract] [Full Text] [Related]

  • 6. Bone mineral density in patients with inflammatory bowel disease: a population-based prospective two-year follow-up study.
    Jahnsen J, Falch JA, Mowinckel P, Aadland E.
    Scand J Gastroenterol; 2004 Feb; 39(2):145-53. PubMed ID: 15000276
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Role of ghrelin and insulin-like growth factor binding protein-3 in the development of osteoporosis in inflammatory bowel disease.
    Koutroubakis IE, Zavos C, Damilakis J, Papadakis G, Neratzoulakis J, Karkavitsas N, Kouroumalis EA.
    J Clin Gastroenterol; 2011 Jul; 45(6):e60-5. PubMed ID: 20921904
    [Abstract] [Full Text] [Related]

  • 10. Updated bone mineral density status in Saudi patients with inflammatory bowel disease.
    Ewid M, Al Mutiri N, Al Omar K, Shamsan AN, Rathore AA, Saquib N, Salaas A, Al Sarraj O, Nasri Y, Attal A, Tawfiq A, Sherif H.
    World J Gastroenterol; 2020 Sep 21; 26(35):5343-5353. PubMed ID: 32994692
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Longitudinal assessment of bone mineral density in children and adolescents with inflammatory bowel disease.
    Schmidt S, Mellström D, Norjavaara E, Sundh V, Saalman R.
    J Pediatr Gastroenterol Nutr; 2012 Nov 21; 55(5):511-8. PubMed ID: 22688562
    [Abstract] [Full Text] [Related]

  • 15. Osteopenia and osteoporosis in Crohn's disease: prevalence in a Dutch population-based cohort.
    Schoon EJ, van Nunen AB, Wouters RS, Stockbrügger RW, Russel MG.
    Scand J Gastroenterol Suppl; 2000 Nov 21; (232):43-7. PubMed ID: 11232491
    [Abstract] [Full Text] [Related]

  • 16. Genetic variants of MTHFR gene in relation to folic acid levels and bone mineral density in Polish patients with inflammatory bowel disease.
    Ratajczak-Pawłowska AE, Hryhorowicz S, Szymczak-Tomczak A, Wysocka E, Michalak M, Kaczmarek-Ryś M, Lis-Tanaś E, Bielawska L, Pławski A, Słomski R, Dobrowolska A, Krela-Kaźmierczak I.
    J Appl Genet; 2024 Feb 21; 65(1):73-81. PubMed ID: 37816983
    [Abstract] [Full Text] [Related]

  • 17. Physical activity, quality of diet and bone mineral density in patients with inflammatory bowel disease.
    Ratajczak-Pawłowska AE, Michalak M, Szymczak-Tomczak A, Rychter AM, Zawada A, Skoracka K, Dobrowolska A, Krela-Kaźmierczak I.
    J Hum Nutr Diet; 2023 Oct 21; 36(5):1692-1700. PubMed ID: 37403249
    [Abstract] [Full Text] [Related]

  • 18. The c.29T>C polymorphism of the transforming growth factor beta-1 (TGFB1) gene, bone mineral density and the occurrence of low-energy fractures in patients with inflammatory bowel disease.
    Krela-Kaźmierczak I, Michalak M, Wawrzyniak A, Szymczak A, Eder P, Łykowska-Szuber L, Kaczmarek-Ryś M, Drwęska-Matelska N, Skrzypczak-Zielińska M, Linke K, Słomski R.
    Mol Biol Rep; 2017 Dec 21; 44(6):455-461. PubMed ID: 28993955
    [Abstract] [Full Text] [Related]

  • 19. Frequency, risk factors, and adverse sequelae of bone loss in patients with ostomy for inflammatory bowel diseases.
    Gupta S, Wu X, Moore T, Shen B.
    Inflamm Bowel Dis; 2014 Feb 21; 20(2):259-64. PubMed ID: 24378598
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the possible risk factors of bone mineral density in subjects with ulcerative colitis and healthy subjects.
    Kaya G, Koçak E, Akbal E, Taş A, Köklü S.
    South Med J; 2011 Nov 21; 104(11):747-51. PubMed ID: 22024784
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.